CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Corbus Pharmaceuticals Holdings, Inc. - CRBP CFD

    5.284
    3.12%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.332
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Corbus Pharmaceuticals Holdings Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 5.124
    Open* 4.914
    1-Year Change* 3895.12%
    Day's Range* 4.884 - 5.604
    52 wk Range 2.11-13.17
    Average Volume (10 days) 23.25K
    Average Volume (3 months) 257.85K
    Market Cap 18.58M
    P/E Ratio -100.00K
    Shares Outstanding 4.42M
    Revenue N/A
    EPS -11.19
    Dividend (Yield %) N/A
    Beta 2.16
    Next Earnings Date Mar 5, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 5.284 0.300 6.02% 4.984 5.604 4.734
    Dec 7, 2023 5.124 -0.670 -11.56% 5.794 5.954 4.934
    Dec 6, 2023 5.854 0.040 0.69% 5.814 6.084 5.804
    Dec 5, 2023 6.054 0.490 8.81% 5.564 6.094 5.564
    Dec 4, 2023 5.914 0.130 2.25% 5.784 6.034 5.594
    Dec 1, 2023 6.064 0.080 1.34% 5.984 6.324 5.984
    Nov 30, 2023 6.334 1.880 42.21% 4.454 6.334 4.454
    Nov 29, 2023 4.694 0.820 21.17% 3.874 4.784 3.874
    Nov 28, 2023 4.094 0.220 5.68% 3.874 4.184 3.874
    Nov 27, 2023 4.134 0.020 0.49% 4.114 4.274 3.944
    Nov 24, 2023 3.784 -0.180 -4.54% 3.964 4.144 3.784
    Nov 22, 2023 3.904 -0.110 -2.74% 4.014 4.284 3.754
    Nov 21, 2023 4.134 -0.110 -2.59% 4.244 4.464 4.114
    Nov 20, 2023 4.294 0.280 6.98% 4.014 4.454 4.014
    Nov 17, 2023 4.254 -0.130 -2.97% 4.384 4.424 4.054
    Nov 16, 2023 4.164 0.100 2.46% 4.064 4.754 3.784
    Nov 15, 2023 4.434 0.930 26.54% 3.504 4.714 3.414
    Nov 14, 2023 3.624 0.330 10.02% 3.294 3.684 3.294
    Nov 13, 2023 3.094 -0.120 -3.73% 3.214 3.454 2.864
    Nov 10, 2023 3.094 -0.090 -2.83% 3.184 3.334 3.004

    Corbus Pharmaceuticals Holdings, Inc. Events

    Time (UTC) Country Event
    Tuesday, March 5, 2024

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 Corbus Pharmaceuticals Holdings Inc Earnings Release
    Q4 2023 Corbus Pharmaceuticals Holdings Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0.88171 3.93723 36.1436 4.82227
    Revenue 0 0.88171 3.93723 36.1436 4.82227
    Total Operating Expense 39.8354 56.8707 126.747 113.248 61.57
    Selling/General/Admin. Expenses, Total 18.6986 20.4254 28.4802 23.6434 12.956
    Research & Development 16.1368 36.4453 98.2672 89.6048 48.614
    Operating Income -39.8354 -55.989 -122.81 -77.1046 -56.7477
    Interest Income (Expense), Net Non-Operating -2.46268 -1.5514 -1.72936 1.06902 1.07557
    Net Income Before Taxes -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Net Income After Taxes -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Net Income Before Extra. Items -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Net Income -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Income Available to Common Excl. Extra. Items -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Income Available to Common Incl. Extra. Items -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Diluted Net Income -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Diluted Weighted Average Shares 4.17068 4.09967 2.60444 2.12976 1.8998
    Diluted EPS Excluding Extraordinary Items -10.1535 -11.1327 -42.7229 -33.5501 -29.3042
    Diluted Normalized EPS -8.95464 -10.9849 -42.7229 -33.5501 -29.3042
    Total Extraordinary Items
    Other, Net -0.04877 11.9 13.2702 4.58184
    Unusual Expense (Income) 5
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0 0 0 0 0
    Revenue 0 0 0 0 0
    Total Operating Expense 8.18899 17.297 10.7968 8.18146 12.34
    Selling/General/Admin. Expenses, Total 3.94029 3.90868 4.55406 4.07327 4.84037
    Research & Development 4.24871 13.3883 6.24276 4.10819 2.49964
    Operating Income -8.18899 -17.297 -10.7968 -8.18146 -12.34
    Interest Income (Expense), Net Non-Operating -0.77751 -0.67729 -0.35778 -0.67798 -0.7002
    Other, Net 0.18266 0.22951 0.27555 0.07771 -0.20868
    Net Income Before Taxes -8.78384 -17.7448 -10.8791 -8.78172 -13.2489
    Net Income After Taxes -8.78384 -17.7448 -10.8791 -8.78172 -13.2489
    Net Income Before Extra. Items -8.78384 -17.7448 -10.8791 -8.78172 -13.2489
    Net Income -8.78384 -17.7448 -10.8791 -8.78172 -13.2489
    Income Available to Common Excl. Extra. Items -8.78384 -17.7448 -10.8791 -8.78172 -13.2489
    Income Available to Common Incl. Extra. Items -8.78384 -17.7448 -10.8791 -8.78172 -13.2489
    Diluted Net Income -8.78384 -17.7448 -10.8791 -8.78172 -13.2489
    Diluted Weighted Average Shares 4.2777 4.18156 4.15711 4.17561 4.1752
    Diluted EPS Excluding Extraordinary Items -2.0534 -4.24359 -2.61698 -2.1031 -3.17324
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -2.0534 -4.24359 -2.61698 -2.1031 -1.97569
    Unusual Expense (Income) 0 0 0 5
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 60.1811 100.205 92.0746 38.1547 44.2403
    Cash and Short Term Investments 59.197 97.6471 85.4334 31.7487 41.7485
    Cash 3.80516 6.75159 1.82578 0.88412 0.80894
    Cash & Equivalents 13.1976 18.255 83.6077 30.8646 40.9395
    Total Receivables, Net 0 2.57833 2.68107
    Prepaid Expenses 0.79162 2.36501 3.71286 3.72493 2.49184
    Other Current Assets, Total 0.19248 0.19248 0.35 0
    Total Assets 66.3119 107.73 102.295 49.1425 46.9893
    Property/Plant/Equipment, Total - Net 5.49807 7.00181 9.31636 10.9029 2.70521
    Property/Plant/Equipment, Total - Gross 8.59129 9.37405 11.6652 12.3088 3.37179
    Accumulated Depreciation, Total -3.09322 -2.37224 -2.34884 -1.40596 -0.66658
    Other Long Term Assets, Total 0.63277 0.52381 0.90394 0.08497 0.04382
    Total Current Liabilities 12.6399 17.0075 31.8978 34.8877 18.0893
    Accounts Payable 2.17396 1.78228 7.38118 11.0914 6.34534
    Accrued Expenses 7.28012 11.2303 23.0095 23.0437 9.85119
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 3.14899 3.86128 0.71016 0.75266 0.39431
    Other Current Liabilities, Total 0.03687 0.13371 0.797 0 1.4985
    Total Liabilities 33.3219 38.6222 57.02 42.9849 19.4652
    Total Long Term Debt 15.9844 15.6363 18.029 0 0
    Other Liabilities, Total 4.69756 5.97842 7.09317 8.09723 1.37589
    Total Equity 32.99 69.108 45.2749 6.15757 27.5241
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.00042 0.01252 0.00989 0.00647 0.00573
    Additional Paid-In Capital 425.196 418.892 349.358 198.975 148.889
    Retained Earnings (Accumulated Deficit) -392.081 -349.734 -304.093 -192.824 -121.37
    Total Liabilities & Shareholders’ Equity 66.3119 107.73 102.295 49.1425 46.9893
    Total Common Shares Outstanding 4.1713 4.17395 3.29476 2.15555 1.90806
    Accounts Receivable - Trade, Net 0 1.6183 2.68107
    Long Term Debt 15.9844 15.6363 18.029
    Short Term Investments 42.1943 72.6405
    Other Equity, Total -0.12609 -0.06245
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 31.206 38.274 45.865 60.1811 67.3478
    Cash and Short Term Investments 28.7332 36.5659 44.227 59.197 66.2292
    Cash 1.99596 1.72889 2.89716 3.80516 3.80611
    Cash & Equivalents 9.25284 6.62046 4.42728 13.1976 8.63754
    Short Term Investments 17.4844 28.2166 36.9026 42.1943 53.7856
    Total Receivables, Net
    Accounts Receivable - Trade, Net
    Prepaid Expenses 2.28026 1.51562 1.44552 0.79162 0.92616
    Other Current Assets, Total 0.19248 0.19248 0.19248 0.19248 0.19248
    Total Assets 36.2834 43.7234 51.6453 66.3119 73.8306
    Property/Plant/Equipment, Total - Net 4.39874 4.76002 5.12041 5.49807 5.87229
    Property/Plant/Equipment, Total - Gross 7.80649 8.01496 8.39551 8.59129 8.78111
    Accumulated Depreciation, Total -3.40775 -3.25494 -3.27509 -3.09322 -2.90883
    Other Long Term Assets, Total 0.6787 0.68937 0.65986 0.63277 0.61048
    Total Current Liabilities 31.5423 16.3859 14.3589 12.6399 17.4692
    Accounts Payable 4.71353 1.50573 1.32299 2.17396 1.37422
    Accrued Expenses 8.94237 7.77604 7.78697 7.28012 6.07764
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 17.8496 7.06725 5.21212 3.14899 9.88364
    Other Current Liabilities, Total 0.03687 0.03687 0.03687 0.03687 0.13371
    Total Liabilities 35.9724 34.2028 35.1863 33.3219 31.8845
    Total Long Term Debt 0.775 13.8194 13.9724 15.9844 9.38585
    Long Term Debt 0.775 13.8194 13.9724 15.9844 9.38585
    Other Liabilities, Total 3.65506 3.99753 6.85501 4.69756 5.02944
    Total Equity 0.31102 9.52059 16.459 32.99 41.9461
    Preferred Stock - Non Redeemable, Net 0 0
    Common Stock 0.00044 0.00044 0.00042 0.00042 0.01253
    Additional Paid-In Capital 428.981 428.153 426.352 425.196 423.342
    Retained Earnings (Accumulated Deficit) -428.663 -418.609 -409.825 -392.081 -381.202
    Other Equity, Total -0.00804 -0.02379 -0.06847 -0.12609 -0.20687
    Total Liabilities & Shareholders’ Equity 36.2834 43.7234 51.6453 66.3119 73.8306
    Total Common Shares Outstanding 4.42368 4.42368 4.21513 4.1713 4.17561
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -42.3469 -45.6404 -111.269 -71.4537 -55.6721
    Cash From Operating Activities -37.5444 -48.1837 -99.6857 -45.7207 -30.0673
    Cash From Operating Activities 0.763 0.99982 1.12385 0.73938 0.49394
    Non-Cash Items 8.06298 12.1534 13.6647 12.5179 8.10229
    Cash Interest Paid 1.96958 1.74088 0.62915 0.02945 0.01044
    Changes in Working Capital -4.02351 -15.6965 -3.20492 12.4757 17.0086
    Cash From Investing Activities 30.0741 -73.4165 -0.48449 -2.74254 -2.30042
    Capital Expenditures -0.01345 -0.05417 -0.48449 -2.74254 -2.30042
    Cash From Financing Activities -0.53362 60.8234 154.875 38.4635 11.4197
    Financing Cash Flow Items 0 -1.82044 -6.03942 -2.57155 -0.69018
    Issuance (Retirement) of Stock, Net 0 62.5861 142.201 40.6771 12.0527
    Issuance (Retirement) of Debt, Net -0.53362 0.05778 18.7135 0.35798 0.05719
    Net Change in Cash -8.00392 -60.7768 54.7047 -9.99978 -20.948
    Other Investing Cash Flow Items, Total 30.0876 -73.3624
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -17.7448 -42.3469 -31.4678 -22.6861 -9.43724
    Cash From Operating Activities -15.115 -37.5444 -30.0895 -22.8444 -10.6153
    Cash From Operating Activities 0.18187 0.763 0.5786 0.3878 0.19572
    Non-Cash Items 1.22002 8.06298 6.78652 5.24585 2.75334
    Cash Interest Paid 0.64146 1.96958 1.40721 0.88743 0.431
    Changes in Working Capital 1.22795 -4.02351 -5.98672 -5.79193 -4.12716
    Cash From Investing Activities 5.5497 30.0741 18.2944 24.2657 42.9622
    Capital Expenditures 0 -0.01345 -0.01345 -0.01345 -0.01345
    Other Investing Cash Flow Items, Total 5.5497 30.0876 18.3078 24.2791 42.9756
    Cash From Financing Activities -0.11301 -0.53362 -0.76794 -0.65723 -0.32713
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0.03706 0 0 0 0
    Issuance (Retirement) of Debt, Net -0.15007 -0.53362 -0.76794 -0.65723 -0.32713
    Net Change in Cash -9.67828 -8.00392 -12.563 0.76403 32.0197
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Ikarian Capital LLC Hedge Fund 4.3462 192260 0 2023-06-30 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.0567 179456 1 2023-06-30 LOW
    Sio Capital Management, LLC Hedge Fund 3.3908 150000 0 2023-06-30 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.7993 79597 9069 2023-06-30 LOW
    Boothbay Fund Management, LLC Investment Advisor/Hedge Fund 0.8585 37976 0 2023-06-30 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7429 32865 0 2023-06-30 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.7143 31600 17919 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2979 13179 0 2023-06-30 LOW
    Moran (Sean F) Individual Investor 0.1501 6642 -1 2023-03-24 LOW
    Tekla Capital Management LLC Investment Advisor 0.1163 5143 0 2023-06-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 0.0758 3353 -12 2023-06-30 LOW
    Cohen (Yuval) Individual Investor 0.074 3274 -1 2023-03-24 LOW
    Morgan Stanley & Co. LLC Research Firm 0.0716 3168 -319 2023-06-30 MED
    Dorsey, Wright & Associates, LLC Investment Advisor/Hedge Fund 0.0578 2555 2555 2023-06-30 HIGH
    Group One Trading, L.P. Research Firm 0.0462 2045 -220 2023-06-30 HIGH
    T. Rowe Price Associates, Inc. Investment Advisor 0.0424 1876 0 2023-08-31 LOW
    BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.0368 1629 0 2023-06-30 LOW
    Catlin (Avery W) Individual Investor 0.0354 1567 0 2023-03-24
    RBC Capital Partners Investment Advisor 0.0342 1512 1512 2023-06-30 HIGH
    Kingsbury Capital Investment Advisors, LLC Investment Advisor 0.0254 1123 1123 2022-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Corbus Pharmaceuticals Company profile

    Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic oral endocannabinoid-mimetic drug to resolve chronic inflammation and fibrotic processes in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus diseases. The company was founded in 2009 and is based in Norwood, Massachusetts.
    Industry: Bio Therapeutic Drugs

    500 River Ridge Drive
    NORWOOD
    MASSACHUSETTS 02062
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    XRP/USD

    0.63 Price
    -5.420% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    71.93 Price
    +0.620% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Gold

    1,999.31 Price
    -0.260% 1D Chg, %
    Long position overnight fee -0.0199%
    Short position overnight fee 0.0117%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    US100

    16,049.90 Price
    -0.160% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading